Skip to content
MS
PW-017 Amino Acid & Nitrogen Metabolism Catabolic unreviewed

Oxidative Deamination

Glutamate (+ glutamine, asparagine) alpha-Ketoglutarate + NH4+
Compartment
Mitochondrial matrix
Main tissue
Liver, kidney
Rate-limiting
Not flagged in the source
Steps
3

Reaction steps

In source order, 3 total

showing 1–3
  1. 1

    L-glutamate + NAD⁺ (or NADP⁺) + H₂O ⇌ α-ketoglutarate + NH₄⁺ + NADH (or NADPH) + H⁺

    Notes

    Glutamate dehydrogenase catalyzes oxidative deamination in the mitochondrial matrix. NAD⁺ is generally the major oxidant during net hepatic glutamate oxidation, although the enzyme can use NADP⁺; the reaction is reversible and is the principal regulated route for release of free ammonia from glutamate.

  2. 2

    L-glutamine + H₂O → L-glutamate + NH₄⁺

    Glutaminase 3.5.1.2 ST-0139 Irreversible H2O
    Notes

    Glutaminase hydrolyzes the amide nitrogen of glutamine in mitochondria; it requires water but no redox cofactor. This irreversible hydrolytic deamidation is not itself oxidative deamination, but it is a major upstream source of mitochondrial glutamate and ammonia in liver, kidney, intestine, and brain.

  3. 3

    L-asparagine + H₂O → L-aspartate + NH₄⁺

    Asparaginase 3.5.1.1 ST-0140 Irreversible H2O
    Notes

    Asparaginase catalyzes irreversible deamidation, providing a smaller additional source of ammonia. The resulting aspartate can be transaminated to oxaloacetate and glutamate or can donate nitrogen to the urea cycle.

Showing all 3 steps.

Regulation

What speeds each enzyme up and what slows it down

Glutamate dehydrogenase

Accelerated by

ADP, GDP; leucine allosterically activates the mammalian enzyme

Inhibited by

ATP, GTP; high-energy charge

Hormonal

Glucagon and cortisol increase hepatic amino-acid catabolic/ureagenic capacity indirectly; insulin suppresses net amino-acid catabolism in the fed state

Hepatic glutaminase

Accelerated by

Glutamine availability; chronic high-protein intake/acidosis can increase expression

Inhibited by

Product accumulation; reduced demand for ammonia disposal

Hormonal

Glucagon can support hepatic ureagenic flux; regulation is largely transcriptional and substrate-driven

Renal glutaminase

Accelerated by

Acidosis, glutamine availability

Inhibited by

Alkalosis reduces net ammoniagenic drive

Hormonal

Cortisol supports renal ammoniagenesis; acid–base status is the dominant physiological regulator

Overview

Oxidative deamination releases the amino nitrogen of glutamate as ammonium while regenerating α-ketoglutarate. In the liver this provides mitochondrial ammonia for carbamoyl phosphate synthesis and the urea cycle; in kidney, ammonium production contributes to acid excretion. Coupling transamination to glutamate dehydrogenase creates the classic transdeamination route by which nitrogen from many amino acids is ultimately disposed of.

Cellular location

Glutamate dehydrogenase (GDH/GLUD) is a mitochondrial matrix enzyme, especially active in liver and kidney and present in brain and other oxidative tissues. Mitochondrial localization places generated NH₄⁺ adjacent to carbamoyl phosphate synthetase I in hepatocytes.

Net energetics

For net GDH oxidation with NAD⁺, one glutamate yields 1 NADH and one NH₄⁺, with no ATP consumed. If NADP⁺ is the acceptor, the reaction yields 1 NADPH instead; subsequent oxidative phosphorylation of NADH can capture energy if reducing equivalents are reoxidized.

Clinical significance

Free ammonia is neurotoxic, so oxidative deamination is tightly coupled to urea synthesis in periportal hepatocytes or to renal ammonium excretion. Activating GLUD1 variants cause hyperinsulinism/hyperammonemia syndrome, partly because leucine-stimulated GDH promotes insulin secretion and excess ammonia generation. Conversely, impaired hepatic ammonia detoxification in severe liver disease produces hyperammonemia and can contribute to hepatic encephalopathy.

Recent literature

Live Europe PMC search

Europe PMC · from cache · sorted by publication date

  1. 1
    The nucleus as a mechanobiological hub in muscle aging.

    Esen O, Battey E, Stroud MJ, Kirby TJ. · 2026-06-18

    open access unreviewed
  2. 2
    The protease code of the bacterial gut microbiota: ecological regulation, barrier disruption, and rewiring host defense and signaling.

    Eckhard U, Ramírez-Larrota JS, Estevan-Morió E, Gomis-Rüth FX. · 2026-06-10

    open access unreviewed
  3. 3
    Dried persimmon peel as a sustainable feed ingredient for goats: Effects on nutrient digestion, energy-nitrogen metabolism, and methane mitigation.

    Zhang X, Yin Q, Hui J, Wu A, Zhu Y, Balasubramanian B, Ge G, Yang J, Liu Z, Deng L, Yao J, Lei X. · 2026-04-01

    open access unreviewed
  4. 4
  5. 5
    Investigation of the In Vitro and In Vivo Metabolism and μ-Opioid Receptor Affinity of the Nitazene N-Pyrrolidino Fluetonitazene.

    Zemp S, Alluisetti G, Weinmann W, Schrag B, Sporkert F, Leclerc M, Grafinger KE. · 2026-06-02

    unreviewed
  6. 6
    Recent advances in piperine and its derivatives as potential anticancer agents.

    Yu QH, Liu Z, Liu J, Bai LP. · 2026-05-21

    open access unreviewed
  7. 7
    Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review.

    Stojanović T, Nilsson KW, Fredriksson R, Schiöth HB, Moulin TC. · 2026-05-08

    open access unreviewed
  8. 8
    Mitochondrial transplantation in lung diseases: From mechanisms to application prospects.

    Wu H, Zhao Q, Zhao Y, Bai J, Pan J, Huang S. · 2025-09-18

    cited 1× open access unreviewed
  9. 9
  10. 10

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.